Is a Hilar Mass Always Cancer? Causes and Diagnosis

A hilar mass is not always cancer, though it understandably triggers alarm when it appears on a chest scan. The hilum is the central area of each lung where the major airways, blood vessels, and lymph nodes converge, and masses in this region have a long list of possible explanations beyond malignancy. Sarcoidosis, tuberculosis, fungal infections, and even vascular abnormalities can all produce a mass or enlarged lymph nodes in the hilum that look worrying on imaging. That said, lung cancer remains one of the most common causes of hilar masses in adults in North America, so these findings always warrant further workup.

Why the Hilum Is a Hotspot for Concerning Findings

The hilum sits at a crossroads. Every breath you take passes through the bronchial tree that branches out from this area, and your entire blood supply to the lungs flows through the pulmonary arteries and veins that thread through it. Dozens of lymph nodes cluster here too, filtering fluid from the lungs and acting as early sentinels for immune reactions, infections, and cancer spread. Because so many structures pack into such a small space, anything that causes swelling, inflammation, or abnormal growth in the area can show up as a “mass” on a chest X-ray or CT scan. That mass could be an actual tumor, a clump of swollen lymph nodes, inflamed tissue, or even a dilated blood vessel.

Malignant Causes of Hilar Masses

When a hilar mass does turn out to be cancer, certain types are more likely culprits than others. Squamous cell carcinoma and small cell carcinoma tend to arise centrally in the lung and commonly present as hilar masses, sometimes with associated airway blockage or collapsed lung tissue downstream. Adenocarcinoma and large cell carcinoma, by contrast, are more often found as peripheral nodules out near the edges of the lung.¹ Small cell carcinoma is especially aggressive. Its classic presentation involves massively enlarged hilar and mediastinal lymph nodes that are easy to spot on imaging, while the original tumor itself can remain tiny and hard to find.²

Beyond primary lung cancer, lymphoma and metastases from cancers originating elsewhere in the body can also cause hilar masses or enlarged hilar lymph nodes. In North America, lung cancer is the most common malignant cause of mediastinal and hilar lymph node enlargement, with lymphoma and metastatic disease from other sites following behind.³ Breast cancer, kidney cancer, and melanoma are among the cancers that can spread to the hilar lymph nodes and mimic a primary lung tumor on imaging.

Sarcoidosis and the Classic Look-Alike

If any single condition competes with cancer for causing hilar masses, it is sarcoidosis. This inflammatory disease triggers clusters of immune cells called granulomas to form in various organs, and the lungs are involved in roughly nine out of ten patients. The hallmark radiologic finding is symmetrical bilateral hilar lymph node enlargement, sometimes accompanied by scattered tiny lung nodules.⁴ Bilateral hilar lymphadenopathy is the single most common finding on imaging in sarcoidosis.⁵

Here is where it gets tricky: sarcoidosis does not always present with the clean, bilateral pattern that textbooks describe. In some cases, the lymph node enlargement is one-sided, producing a unilateral hilar mass that looks almost indistinguishable from lung cancer on a scan. One case report emphasized this exact problem, noting that even when a hilar tumor mass is “highly suggestive of lung cancer,” the diagnosis should only be confirmed after tissue examination, because conditions like sarcoidosis can mimic it convincingly.⁶ The point is not that sarcoidosis is common as a cancer mimic, but that it happens often enough that no one should assume a hilar mass is malignant based on imaging alone.

Infections That Mimic Cancer

A range of infections can produce hilar masses or enlarged hilar nodes that raise suspicion for malignancy. Tuberculosis is the classic example. In areas where TB is prevalent, hilar and mediastinal lymph node enlargement is a hallmark of the disease, especially in children. Fungal infections are another well-documented group of mimics. Histoplasmosis, coccidioidomycosis, blastomycosis, aspergillosis, and cryptococcosis can all produce radiologic findings that look like primary lung cancer.⁷ These infections are more common in specific geographic regions. Histoplasmosis, for instance, is concentrated in the Ohio and Mississippi River valleys in the United States, while coccidioidomycosis clusters in the desert Southwest.

What makes infectious mimics especially challenging is that they can produce a single mass, not just diffuse inflammation. A granuloma from a healed histoplasmosis infection can sit in the hilum for years, calcify partially, and look like a suspicious nodule on a routine scan. Even PET scans, which detect metabolic activity and are often used to help distinguish cancer from benign findings, can be fooled by active infections. In one study evaluating pulmonary lesions with PET scanning, the false-positive results included tuberculosis, a granulomatous lesion, and an inflammatory lesion, all of which lit up on the scan as if they were cancer.⁸

Vascular Structures Posing as Masses

Sometimes what looks like a hilar mass on imaging is not a mass at all. The hilum is packed with large blood vessels, and certain vascular abnormalities can create the appearance of a tumor. A pulmonary artery aneurysm, for example, can show up on a standard chest X-ray as an apparent hilar mass that is indistinguishable from a neoplasm.⁹ An enlarged pulmonary artery from pulmonary hypertension can have a similar effect. These “pseudomasses” are usually sorted out quickly once a contrast-enhanced CT scan or MRI is performed, because these tools can clearly distinguish blood vessels from solid tissue. MRI is especially good at differentiating vascular from nonvascular structures without requiring intravenous contrast dye, which makes it useful for patients who are allergic to contrast agents.¹⁰

How Imaging Helps Narrow the Possibilities

The initial discovery of a hilar mass usually happens on a chest X-ray or a CT scan done for some other reason. From there, several imaging characteristics help doctors start sorting cancer from non-cancer causes. Size matters: European screening guidelines suggest that hilar or mediastinal lymph nodes measuring over 15 mm on the short axis warrant further investigation or at least a follow-up scan in three to six months. Below that threshold, unnecessary referrals become common.¹¹

Pattern also matters. Bilateral, symmetric hilar enlargement strongly suggests sarcoidosis or a systemic process rather than cancer. The presence and pattern of calcification within the nodes can offer further clues. In sarcoidosis, calcification tends to be focal and scattered, while in tuberculosis, lymph nodes are more likely to be completely calcified. When hilar node calcification is present, bilateral involvement is far more common in sarcoidosis than in TB.¹²

PET/CT scanning adds metabolic information to the structural picture from a regular CT. Cancerous tissue tends to consume more glucose than normal tissue, so it “lights up” on a PET scan. Combining PET with CT reduces false-positive readings compared to CT alone. In one large prospective study comparing PET/CT with CT for staging non-small cell lung cancer, CT alone produced 112 false-positive node interpretations, while integrated PET/CT cut that number nearly in half to 58.¹³ Even so, PET scanning is not perfect. Active infections and inflammatory conditions like sarcoidosis can produce false-positive results, which is why imaging alone rarely gives a definitive answer.

MRI plays a more specialized role. It does not replace CT for routine lung evaluation, but it excels at distinguishing tissue from blood vessels in the hilum and mediastinum. In one comparison, MRI provided diagnostic information equal to contrast-enhanced CT in about 90% of patients evaluated for hilar and mediastinal abnormalities.¹⁴ MRI can also serve as the first-line imaging study when a vascular lesion or mediastinal mass is suspected.¹⁵

Getting a Tissue Diagnosis

When imaging cannot confidently rule out cancer, the next step is almost always a biopsy. For hilar and mediastinal masses, one of the most effective and least invasive options is endobronchial ultrasound-guided transbronchial needle aspiration, commonly called EBUS-TBNA. A thin, flexible scope is passed through the airway, and real-time ultrasound guides a needle into the suspicious lymph node or mass. This can be done without general anesthesia and avoids the need for a surgical procedure.¹⁶

Results from EBUS-TBNA are generally strong but not flawless. In one Italian case series, the procedure was successfully performed in all patients and yielded a diagnosis in about 89% of cases, with a sensitivity above 92% and no complications. Among the positive samples, the diagnoses included lung cancer, sarcoidosis, and tuberculosis, illustrating how the same procedure can identify both malignant and benign conditions.¹⁷ A separate real-world study found somewhat lower sensitivity, around 55% across all types of disease, with false negatives sometimes occurring because certain accessible nodes simply were not sampled during the procedure.¹⁸ The gap between those numbers reflects the difference between specialized centers and general clinical practice, a common theme in procedural medicine.

When bronchoscopy does not yield a diagnosis, CT-guided needle biopsy is an alternative. In one series of patients with hilar masses who had already undergone non-diagnostic bronchoscopy, CT-guided biopsy with a fine needle achieved a diagnosis of malignancy in 95% of cases.¹⁹ Surgical biopsy through mediastinoscopy or video-assisted thoracic surgery remains the fallback for cases where less invasive methods fail, though the development of EBUS has significantly reduced the need for these more involved procedures.

What Happens When the Diagnosis Is Not Obvious

Not every hilar finding demands an immediate biopsy. For enlarged lymph nodes that fall into a gray zone, many physicians opt for a strategy of watchful waiting with periodic imaging. A survey of physicians found that for nodes in the 10-to-14 mm range that are not biopsied right away, most doctors order a repeat CT scan in three months, and roughly four in ten wait six months for the first follow-up. If the nodes remain stable in size, follow-up scans continue every six to twelve months.²⁰ For smaller nodes at or below 10 mm, very few doctors continue surveillance past two years. For larger nodes above 20 mm, about a quarter of physicians keep scanning beyond that timeframe.

The decision of when to biopsy versus when to watch involves weighing the patient’s individual risk. A 70-year-old with a smoking history and a growing hilar mass gets treated very differently from a 30-year-old non-smoker with stable bilateral hilar lymph nodes. The same survey found that most physicians consider referring for EBUS-TBNA once lymph nodes reach 11 to 15 mm.²⁰ Below that, the risk of cancer is low enough that follow-up imaging is usually sufficient.

Hilar Masses in Children

The calculus changes substantially in pediatric patients. Children’s lymphatic systems are highly active, and the range of causes for hilar lymph node enlargement skews heavily toward infections and reactive processes rather than cancer.²¹ Tuberculosis is the dominant concern in many parts of the world. In a CT study of pediatric TB patients, hilar lymph node involvement was found in the vast majority of cases, often bilateral and frequently in multiple locations simultaneously.²² The enlarged nodes in childhood TB often show a characteristic ring-shaped pattern of contrast enhancement on CT, which can help distinguish them from lymphoma or other causes.²²

Chest X-rays can pick up hilar and paratracheal lymphadenopathy in children, and the lateral view is particularly useful for spotting enlarged lymph nodes in the subcarinal space, behind the heart.²³ While childhood cancers like lymphoma and neuroblastoma can certainly cause hilar masses, the odds are significantly tilted toward benign explanations compared to adults, especially in regions where TB and other infections are common.

The Anxiety of Waiting

For the person sitting in a doctor’s office being told about a suspicious finding on their chest scan, the medical nuance matters less than one overwhelming question: is it cancer? Research shows this anxiety is substantial and underappreciated. About a quarter of patients with incidentally discovered pulmonary nodules experience clinically significant distress, and their knowledge about the actual risk of cancer and what the evaluation involves tends to be poor.²⁴ Most nodules and many hilar findings turn out to be benign, but the weeks or months of surveillance scans and waiting can take a real psychological toll.

Good communication from doctors helps, though the picture is more complicated than simply providing information. One quality improvement study found that giving patients a fact sheet about pulmonary nodules led to a statistically significant improvement in their sense of understanding their situation, with 95% of patients reporting they felt better informed afterward.²⁵ Yet another study found that communication strategies focused solely on explaining the risk of cancer may not be enough to reduce distress. The emotional weight of the finding seems to persist even when patients intellectually understand that the odds of cancer are low.²⁶ If you find yourself in this situation, asking your doctor specifically about the features of your finding that point toward or away from cancer, rather than waiting for them to volunteer that information, can be a practical way to get the reassurance or the urgency that matches your actual risk.

When Airway Involvement Complicates the Picture

One feature that raises concern when a hilar mass is present is whether it involves the airways. A mass that wraps around or compresses the bronchial tree causes symptoms like cough, wheezing, or shortness of breath and tends to signal more advanced disease when the cause is cancer. In a CT study of small cell lung cancer, about 85% of patients had evidence of airway involvement, and when a hilar mass was combined with mediastinal extension, the frequency of major airway compression was even higher.²⁷ Airway involvement is not exclusive to cancer, though. Tuberculosis in children frequently causes bronchial compression, especially of the left main bronchus, from surrounding lymph node enlargement.²² The presence of airway compression tells the doctor the finding needs attention, but it does not automatically confirm malignancy.